|
|
|
|
KaletraCay Compass, ...to lower the price on the AIDS drug Kaletra after threatening to break the patent and produce the drug itself at government laboratories. ... Brazilian Official at Latin American Conference on AIDS Calls for ... Jan 13, 2006 Kaiser network.org, Laboratories said they had reached an agreement for Abbott to keep the government's annual expenses on the company's antiretroviral drug Kaletra at current ... ICAAC: Pilot study shows dual protease inhibitor regimen as safe ... Jan 4, 2006 Aidsmap, A dual protease inhibitor regimen consisting of ritonavir-boosted lopinavir (Kaletra) with saquinavir is as effective and safe as a traditional regimen ... AIDS prevention treatment uneven Jan 12, 2006 Toronto Star, The treatment regimen — using commonly prescribed combinations of anti-AIDS drugs known as Combivir and Kaletra — costs about $1,200 for a round of therapy ... Roche to share know-how in making protease inhibitors with poorest ... Jan 13, 2006 Aidsmap, Other protease inhibitors that might be used in second-line treatment are Kaletra (lopinavir/ritonavir), which is offered to least developed and sub-Saharan ... ICAAC: HCV only factor associated with liver problems in patients ... Jan 8, 2006 Aidsmap, ...copies/ml. The most frequently prescribed drugs were Kaletra (39%), efavirenz (Sustiva)(43%), and abacavir (Ziagen) (31%). A total ... ICAAC: Achillion reveals potential for once weekly dosing of ... Dec 19, 2005 Aidsmap, The study recruited 24 patients, all of whom received lopinavir/ritonavir (Kaletra) twice daily plus either 5 or 10mg of elvucitabine once daily or 20mg every ... Study finds antiretroviral therapy cost-effective in South African ... Jan 9, 2006 Aidsmap, However, the most common second-line regimen, which is anchored by the brand name protease inhibitor Kaletra, is roughly three times as costly. ... Dazed and confused: the reality of Aids treatment in South Africa Jan 11, 2006 Open Democracy, ...as possible: Brazil’s government went head-to-head with the pharmaceutical company Abbott in July 2005 in a bid to wrestle the patent of ARV Kaletra from the ... The Lamebow awards Jan 3, 2006 San Francisco Bay Guardian, ...when the Food and Drug Administration forced Abbott Laboratories to pull its ubiquitous "Where do you see yourself in five years?" Kaletra campaign because the ... Brazil's grass-roots fight against AIDS Jan 7, 2006 St. Petersburg Times, After tough bargaining that ended in early October, Abbott Labs agreed to reduce by nearly half the price of its AIDS drug Kaletra. ... Government drags its feet on patents for AIDS drugs Dec 26, 2005 Newindpress, ...any objections. The ARVs whose patents are awaiting include Abacavir, Combivir, Trizivir, Kaletra, Lexiva and Efavirenz. Combivir ... Africa: New Drugs Urgently Needed Dec 15, 2005 AllAfrica.com, For example, Abbott Laboratories, the sole manufacturer of Kaletra - an expensive combination of the second-generation drugs, lopinavir and ritonavir ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |